The optimal target for acute glycemic control in critically ill patients: A network meta-analysis.
The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Abstract
Purpose The optimal target blood glucose concentration for acute glycemic control remains unclear because few studies have directly compared 144-180 with 110-144 or >180 mg/dL. Accordingly, we performed a network meta-analysis to compare four different target blood glucose levels ( 180 mg/dL) in terms of the benefit and risk of insulin therapy. Methods We included all of the studies from three systematic reviews and searched the PubMed and Cochrane databases for other studies investigating glucose targets among critically ill patients. The primary outcome was hospital mortality, and the secondary outcomes were sepsis or bloodstream infection and the risk of hypoglycemia. Network meta-analysis to identify an optimal target glucose concentration. Results The network meta-analysis included 18,098 patients from 35 studies. There were no significant differences in the risk of mortality and infection among the four blood glucose ranges overall or in subgroup analysis. Conversely, target concentrations of 180 mg/dL. However, there were no significant differences between the target concentrations of 144-180 and >180 mg/dL. Conclusions This network meta-analysis found no significant difference in the risk of mortality and infection among four target blood glucose ranges in critically ill patients, but indicated that target blood glucose levels of 180 mg/dL. Further studies are required to refute or confirm our findings.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“No significant difference in the risk of hospital mortality was observed between the four blood glucose ranges.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [519]
In the citing paper
“Target concentrations of < 110 and 110–144 mg/dL were associated with a four to nine-fold increase in the risk of hypoglycemia compared with 144–180 and > 180 mg/dL.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [519]
In the citing paper
“No significant difference in the risk of hypoglycemia comparing a target of 144–180 and > 180 mg/dL was demonstrated (OR 1.72; 95% CI 0.79–3.7).”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [519]
Citations
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,171
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 2×
“In 2009, the landmark Normoglycemia in Intensive Care Evaluation and Surviving Using Glucose Algorithm Regulation (NICE-SUGAR) trial reported that IIT (target blood glycemic range, 80–108 mg/dL) increased mortality among critical ill patients compared with an intermediate level of glycemic control (144–180 mg/dL) [9].”
BackgroundFamily history of subarachnoid haemorrhage: supplemental value of scrutinizing all relatives.
Greebe, P., Bromberg, J. E., Rinkel, G. J., Algra, A., & van Gijn, J. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.3.273 · Cited by 4,139
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 1×
“Subsequently, several studies reported that tight glycemic control reduced mortality and morbidity at certain centers and in selected populations [3, 4].”
BackgroundIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Graphical tools for network meta-analysis in STATA
Chaimani, A., Higgins, J. P. T., Mavridis, D., Spyridonos, P., & Salanti, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076654 · Cited by 2,473 · cited 2×
“The integration of direct evidence with indirect evidence increases the precision of the estimates and produces a relative ranking of all treatments for the studied outcome [15].”
BackgroundStandards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Effect of an Intensive Glucose Management Protocol on the Mortality of Critically Ill Adult Patients
Krinsley, J. S. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.8.992 · Cited by 1,223 · cited 1×
“Subsequently, several studies reported that tight glycemic control reduced mortality and morbidity at certain centers and in selected populations [3, 4].”
BackgroundHypoglycemia and risk of death in critically ill patients
The NICE-SUGAR Study Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204942 · Cited by 1,009 · cited 1×
“Although there is no evidence to suggest that such acute hypoglycemia would directly worsen patient outcomes, the increased risk of hypoglycemia during tight glycemic control in critically ill patients might result in undesirable adverse effects, as even moderate hypoglycemia has been associated with poor outcomes [8].”
BackgroundPreiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1585-2 · Cited by 911
Clinical review: intensive care unit acquired weakness
Hermans, G., & Van den Berghe, G. (2015) · Critical Care · doi:10.1186/s13054-015-0993-7 · Cited by 792 · cited 1×
“Furthermore, hyperglycemia might be an independent risk factor for ICU-acquired weakness [7].”
BackgroundJacobi, J., Bircher, N., Krinsley, J., Agus, M., Braithwaite, S. S., Deutschman, C., Freire, A. X., Geehan, D., Kohl, B., Nasraway, S. A., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182653269 · Cited by 571 · cited 5×
“Although the current guidelines do not recommend target blood glucose levels of both <110 and >180 mg/dL, it remains ambiguous whether target blood glucose levels of 110–144 or 144–180 mg/dL are superior [11, 55].”
BackgroundResultInfluentialArabi, Y. M., Dabbagh, O. C., Tamim, H. M., Al-Shimemeri, A. A., Memish, Z. A., Haddad, S. H., Syed, S. J., Giridhar, H. R., Rishu, A. H., Al-Daker, M. O., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818f21aa · Cited by 471
Skapinakis, P., Caldwell, D. M., Hollingworth, W., Bryden, P., Fineberg, N. A., Salkovskis, P., Welton, N. J., Baxter, H., Kessler, D., Churchill, R., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30069-4 · Cited by 407
Network meta-analysis-highly attractive but more methodological research is needed
Li, T., Puhan, M. A., Vedula, S. S., Singh, S., Dickersin, K., & The Ad Hoc Network Meta-analysis Methods Meeting Working Group (2011) · BMC Medicine · doi:10.1186/1741-7015-9-79 · Cited by 361
Arabi, Y. M., Tamim, H. M., Dhar, G. S., Al-Dawood, A., Al-Sultan, M., Sakkijha, M. H., Kahoul, S. H., & Brits, R. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.005074 · Cited by 353
De La Rosa, G. D. C., Donado, J. H., Restrepo, A. H., Quintero, A. M., González, L. G., Saldarriaga, N. E., Bedoya, M., Toro, J. M., Velásquez, J. B., Valencia, J. C., et al. (2008) · Critical Care · doi:10.1186/cc7017 · Cited by 319
Treatment of Hyperglycemia In Ischemic Stroke (THIS): A Randomized Pilot Trial
Bruno, A., Kent, T. A., Coull, B. M., Shankar, R. R., Saha, C., Becker, K. J., Kissela, B. M., & Williams, L. S. (2008) · Stroke · doi:10.1161/strokeaha.107.493544 · Cited by 265
Reduction of Nosocomial Infections in the Surgical Intensive-Care Unit by Strict Glycemic Control
Grey, N. J., & Perdrizet, G. A. (2004) · Endocrine Practice · doi:10.4158/ep.10.s2.46 · Cited by 258
Bilotta, F., Spinelli, A., Giovannini, F., Doronzio, A., Delfini, R., & Rosa, G. (2007) · Journal of Neurosurgical Anesthesiology · doi:10.1097/ana.0b013e3180338e69 · Cited by 243
Strict versus moderate glucose control after resuscitation from ventricular fibrillation
Oksanen, T., Skrifvars, M. B., Varpula, T., Kuitunen, A., Pettilä, V., Nurmi, J., & Castrén, M. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0876-8 · Cited by 238
Intensive Insulin Therapy After Severe Traumatic Brain Injury: A Randomized Clinical Trial
Bilotta, F., Caramia, R., Cernak, I., Paoloni, F. P., Doronzio, A., Cuzzone, V., Santoro, A., & Rosa, G. (2008) · Neurocritical Care · doi:10.1007/s12028-008-9084-9 · Cited by 210
Benefits and Risks of Tight Glucose Control in Critically Ill Adults: A Meta-analysis
Wiener, R. S., Wiener, D. C., & Larson, R. J. (2008) · JAMA · doi:10.1001/jama.300.8.933 · Cited by 200
Tight computerized versus conventional glucose control in the ICU: a randomized controlled trial
Kalfon, P., Giraudeau, B., Ichaï, C., Guerrini, A., Bréchot, N., Cinotti, R., Dequin, P., Riu-Poulenc, B., Montravers, P., Annane, D., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-013-3189-0 · Cited by 174
Safety and Efficacy of Intensive Insulin Therapy in Critical Neurosurgical Patients
Bilotta, F., Caramia, R., Paoloni, F. P., Delfini, R., & Rosa, G. (2009) · Anesthesiology · doi:10.1097/aln.0b013e318198004b · Cited by 161
Bayesian Graphical Models using MCMC
Plummer, M. (2016) · Cited by 157
Shyangdan, D. S., Uthman, O. A., & Waugh, N. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-009417 · Cited by 149 · cited 1×
“The DIC measures the fit of the model, while penalizing it for the number of effective parameters; the most appropriate model has the lowest DIC value [19].”
MethodIntensive Insulin Therapy in Severe Traumatic Brain Injury: A Randomized Trial
Coester, A., Neumann, C. R., & Schmidt, M. I. (2010) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3181c9afc2 · Cited by 139
Walters, M. R., Weir, C. J., & Lees, K. R. (2006) · Cerebrovascular Diseases · doi:10.1159/000093239 · Cited by 122
Intensive versus intermediate glucose control in surgical intensive care unit patients
Okabayashi, T., Shima, Y., Sumiyoshi, T., Kozuki, A., Tokumaru, T., Iiyama, T., Sugimoto, T., Kobayashi, M., Yokoyama, M., & Hanazaki, K. (2014) · Diabetes Care · doi:10.2337/dc13-1771 · Cited by 119
Intensive Versus Conventional Insulin Therapy in Critically Ill Neurologic Patients
Green, D. M., O’Phelan, K. H., Bassin, S. L., Chang, C. W. J., Stern, T., & Asai, S. M. (2010) · Neurocritical Care · doi:10.1007/s12028-010-9417-3 · Cited by 105
Singh, J. A., Hossain, A., Ghogomu, E. T., Kotb, A., Christensen, R., Mudano, A. S., Maxwell, L. J., Shah, N. P., Tugwell, P., & Wells, G. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012183 · Cited by 104 · cited 1×
“Recently, the methodology for network meta-analyses was established and it was made statistically possible to compare groups even when a direct comparison was not originally performed [13, 14].”
MethodEgi, M., Finfer, S. R., & Bellomo, R. (2011) · CHEST Journal · doi:10.1378/chest.10-1478 · Cited by 95
Self-citationChan, R. P. C., Galas, F. R. B. G., Hajjar, L. A., Bello, C. N., Piccioni, M. A., & Auler, J. O. C. (2009) · Clinics · doi:10.1590/s1807-59322009000100010 · Cited by 83
Bland, D. K., Fankhanel, Y., Langford, E., Lee, M., Lee, S. W., Maloney, C., Rogers, M., & Zimmerman, G. (2005) · American Journal of Critical Care · doi:10.4037/ajcc2005.14.5.370 · Cited by 64
Tight glycemic control may favor fibrinolysis in patients with sepsis*
Savioli, M., Cugno, M., Polli, F., Taccone, P., Bellani, G., Spanu, P., Pesenti, A., Iapichino, G., & Gattinoni, L. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819542da · Cited by 58
Effects of intensive glycemic control on outcomes of cardiac surgery
Giakoumidakis, K., Eltheni, R., Patelarou, E., Theologou, S., Patris, V., Michopanou, N., Mikropoulos, T., & Brokalaki, H. (2013) · Heart & Lung · doi:10.1016/j.hrtlng.2012.12.007 · Cited by 58
Lowering of Glucose in Critical care: a randomized pilot trial
McMullin, J., Brożek, J., McDonald, E., Clarke, F. J., Jaeschke, R., Heels‐Ansdell, D., Leppert, R., Foss, A., & Cook, D. (2007) · Journal of Critical Care · doi:10.1016/j.jcrc.2006.08.002 · Cited by 56
Mitchell, I., Knight, E., Gissane, J., Tamhane, R., Kolli, R., Leditschke, I. A., Bellomo, R., & Finfer, S. (2006) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)02060-4 · Cited by 54
Friedrich, J. O., Chant, C., & Adhikari, N. K. (2010) · Critical Care · doi:10.1186/cc9240 · Cited by 53
Tight glycemic control does not affect asymmetric-dimethylarginine in septic patients
Iapichino, G., Albicini, M., Umbrello, M., Sacconi, F., Fermo, I., Pavlovich, R., Paroni, R. C., Bellani, G., Mistraletti, G., Cugno, M., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1158-9 · Cited by 50
Dyslipidemia: a prospective controlled randomized trial of intensive glycemic control in sepsis
Cappi, S. B., Noritomi, D. T., Velasco, I. T., Curi, R., Alba‐Loureiro, T. C., & Soriano, F. G. (2012) · Intensive Care Medicine · doi:10.1007/s00134-011-2458-z · Cited by 46
de Azevedo, J. R. A., de Araujo, L. O., da Silva, W. S., & de Azevedo, R. P. (2009) · Journal of Critical Care · doi:10.1016/j.jcrc.2008.10.011 · Cited by 43
Intensive insulin therapy for septic patients: A meta-analysis of randomized controlled trials.
Song, F., Zhong, L.-J., Han, L., Xie, G.-H., Xiao, C., Zhao, B., Hu, Y.-Q., Wang, S.-Y., Qin, C.-J., Zhang, Y., et al. (2014) · BioMed Research International · doi:10.1155/2014/698265 · Cited by 35
Insulin therapy of hyperglycemia in intensive care.
Farah, R. E., Samokhvalov, A., Zviebel, F., & Makhoul, N. M. (2007) · PubMed · Cited by 35
Davies, R. R., Newton, R. W., McNeill, G. P., Fisher, B. M., Kesson, C. M., & Pearson, D. (1991) · Scottish Medical Journal · doi:10.1177/003693309103600303 · Cited by 32
Hsu, C.-W., Sun, S., Lin, S.-L., Huang, H.-H., & Wong, K.-F. (2012) · Critical Care · doi:10.1186/cc11299 · Cited by 31
Henderson, W. R., Dhingra, V. K., Chittock, D. R., Foster, D., Hébert, P. C., Cook, D., Heyland, D. K., Dodek, P., Griesdale, D. E. G., Schulzer, M., et al. (2009) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.733 · Cited by 21
Yin, S., Zhang, D., Du, H., Du, H., Yin, Z., & Qiu, Y. (2015) · PubMed Central · Cited by 21
Mahmoodpoor, A., Aliasgharzadeh, A., Parish, M., Amir-Aslanzadeh, Z., & Abedini, N. (2011) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.273.468 · Cited by 12
Research works printed but not linked: 1
- Mackenzie IM, Ercole A, Ingle S, Palmer CR (2008) Glycaemic control and outcome in general intensive care: the East Anglian GLYCOGENIC study. Br J Intensive Care 18:121–126
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
ESPEN guideline on clinical nutrition in the intensive care unit.
Singer, P., Blaser, A. R., Berger, M. M., Alhazzani, W., Calder, P. C., Casaer, M. P., Hiesmayr, M., Mayer, K., Montejo, J. C., Pichard, C., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.08.037 · Cited by 2,904
ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit
Singer, P., Blaser, A. R., Berger, M. M., Calder, P. C., Casaer, M., Hiesmayr, M., Mayer, K., Montejo-Gonzalez, J. C., Pichard, C., Preiser, J.-C., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.07.011 · Cited by 793
“The glycemic target associated with the best adjusted outcome ranges from 80 to 150 to 140 e 180 mg/dL (7.8 e 10 mmol/L), which is different from the blood glucose levels actually achieved [139].”
BackgroundInfluentialPeden, C. J., Aggarwal, G., Aitken, R. J., Anderson, I. D., Bang Foss, N., Cooper, Z., Dhesi, J. K., French, W. B., Grant, M. C., Hammarqvist, F., et al. (2021) · World Journal of Surgery · doi:10.1007/s00268-021-05994-9 · Cited by 171
Metadata
- Authors
- Yatabe, T., Inoue, S., Sakaguchi, M., & Egi, M.
- Affiliations
- Kōchi University (JP)
- Tokai University Hachioji Hospital (JP)
- Kobe University Hospital (JP)
- Corresponding author
- Egi, Moritoki
- Venue
- Intensive Care Medicine
- Published
- 2016-09-29
- Volume
- 43
- Issue
- 1
- Pages
- 16-28
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2525551153
- Semantic Scholar
- ea31613a90266d8f04dfe741f9bf9801f6bd49e4
- Cited by
- 95
- References
- 57
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 17 · 2023: 11 · 2022: 7 · 2021: 9 · 2020: 13 · 2019: 12 · 2018: 8 · 2017: 4 · 2016: 1
- FWCI
- 8.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Intensive Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (16K10936)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- glycemic control, glycemic targets, critically ill patients, insulin therapy, hypoglycemia, in-hospital mortality, sepsis, bloodstream infection, intensive care
- MeSH terms
- Adult, Aged, Aged, 80 and over, Blood Glucose, Female, Humans, Hyperglycemia, Hypoglycemia, Hypoglycemic Agents, Male, Middle Aged, Critical Illness, Drug Dosage Calculations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.